Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MAEN HUSSEIN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1356332506
CMS profile
333099
Location
TAVARES, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$37,505.72

196 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $6,544.62 11
PFIZER INC. $5,320.92 9
Janssen Biotech, Inc. $3,000.23 11
BeiGene USA, Inc. $2,840.57 6
PharmaEssentia USA Corporation $2,781.73 3
MorphoSys, US Inc. $2,591.11 4
Janssen Scientific Affairs, LLC $2,532.50 2
AVEO Pharmaceuticals, Inc. $1,829.56 2
AstraZeneca Pharmaceuticals LP $1,827.58 8
Stemline Therapeutics Inc. $1,590.65 3
Exelixis Inc. $1,558.88 1
Eli Lilly and Company $800.00 1
Celgene Corporation $687.13 15
ABBVIE INC. $461.80 2
Incyte Corporation $363.01 6
NOVARTIS PHARMACEUTICALS CORPORATION $319.01 13
Merck Sharp & Dohme LLC $255.53 12
Kite Pharma, Inc. $218.97 6
Daiichi Sankyo Inc. $218.42 6
Seagen Inc. $211.98 10
Adaptive Biotechnologies Corporation $210.63 3
Pharmacyclics LLC, An AbbVie Company $200.54 8
Regeneron Healthcare Solutions, Inc. $118.11 4
GENZYME CORPORATION $89.78 4
Eisai Inc. $78.62 4
Genentech USA, Inc. $78.06 4
Lilly USA, LLC $68.14 3
Bayer Healthcare Pharmaceuticals Inc. $61.31 3
Genmab U.S., Inc. $58.91 2
Astellas Pharma US Inc $49.15 3
Amgen Inc. $43.05 2
Pharmacosmos Therapeutics Inc. $41.44 2
Ipsen Biopharmaceuticals, Inc $39.61 2
G1 Therapeutics, Inc. $39.54 2
Gilead Sciences, Inc. $38.89 2
JAZZ PHARMACEUTICALS INC. $37.11 2
CTI BioPharma Corp. $36.82 2
ImmunoGen, Inc. $27.82 1
Takeda Pharmaceuticals U.S.A., Inc. $24.54 1
Telix Pharmaceuticals $22.93 1
Rigel Pharmaceuticals, Inc. $22.78 1
TerSera Therapeutics LLC $21.65 1
Blueprint Medicines Corporation $20.36 1
SERVIER PHARMACEUTICALS LLC $20.14 1
Alexion Pharmaceuticals, Inc. $19.00 1
ADC Therapeutics America, Inc. $18.17 1
Agios Pharmaceuticals, Inc. $16.84 1
ARRAY BIOPHARMA INC $16.50 1
Mirati Therapeutics, Inc. $15.91 1
GlaxoSmithKline, LLC. $15.17 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

196 matching records · $37,505.72 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 196 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 196.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Exelixis Inc. $1,558.8812/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062014461 CMS
Daiichi Sankyo Inc. $16.1512/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006577349 CMS
Merck Sharp & Dohme LLC $20.4712/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048896677 CMS
Adaptive Biotechnologies Corporation $93.8712/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261022973417 CMS
GlaxoSmithKline, LLC. $15.1711/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001631603 CMS
CTI BioPharma Corp. $19.7111/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261039693027 CMS
JAZZ PHARMACEUTICALS INC. $20.7411/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261058424475 CMS
AstraZeneca Pharmaceuticals LP $25.4311/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014906309 CMS
Novartis Pharmaceuticals Corporation $0.5211/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992232059 CMS
Novartis Pharmaceuticals Corporation $20.9211/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992232063 CMS
Celgene Corporation $15.6211/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015552425 CMS
GENZYME CORPORATION $27.6911/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049978919 CMS
E.R. Squibb & Sons, L.L.C. $16.8711/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015552421 CMS
E.R. Squibb & Sons, L.L.C. $988.0011/14/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015552413 CMS
Merck Sharp & Dohme LLC $23.8511/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048598103 CMS
AstraZeneca Pharmaceuticals LP $28.0111/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015946465 CMS
AVEO Pharmaceuticals, Inc. $14.5611/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049062057 CMS
G1 Therapeutics, Inc. $17.5811/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059919109 CMS
Celgene Corporation $125.7511/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015552429 CMS
Celgene Corporation $232.8111/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015552433 CMS
Kite Pharma, Inc. $22.3511/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025269915 CMS
MorphoSys, US Inc. $2,320.0011/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261060325167 CMS
MorphoSys, US Inc. $117.9011/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261060325169 CMS
AstraZeneca Pharmaceuticals LP $21.1611/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011594635 CMS
AVEO Pharmaceuticals, Inc. $1,815.0011/01/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049062053 CMS
E.R. Squibb & Sons, L.L.C. $1,729.0010/30/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015552389 CMS
Novartis Pharmaceuticals Corporation $17.1610/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992232055 CMS
Daiichi Sankyo Inc. $125.0010/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006589049 CMS
E.R. Squibb & Sons, L.L.C. $19.5710/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015552385 CMS
AstraZeneca Pharmaceuticals LP $1,665.0010/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014191085 CMS
MorphoSys, US Inc. $21.8410/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261060325165 CMS
Eli Lilly and Company $800.0010/19/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261031786613 CMS
Merck Sharp & Dohme LLC $20.4010/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048937345 CMS
Celgene Corporation $16.8710/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015552417 CMS
Seagen Inc. $20.0010/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995728763 CMS
Janssen Scientific Affairs, LLC $1,362.5010/10/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988432633 CMS
Lilly USA, LLC $17.3510/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261031908215 CMS
Merck Sharp & Dohme LLC $20.7210/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048598107 CMS
BeiGene USA, Inc. $16.2510/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051188277 CMS
Pharmacosmos Therapeutics Inc. $24.6610/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261046251489 CMS
Janssen Biotech, Inc. $23.0510/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988112481 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.5410/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055411583 CMS
SERVIER PHARMACEUTICALS LLC $20.1410/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055090585 CMS
Alexion Pharmaceuticals, Inc. $19.0009/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017002527 CMS
PFIZER INC. $14.2409/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049825877 CMS
Gilead Sciences, Inc. $24.5309/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025654397 CMS
E.R. Squibb & Sons, L.L.C. $13.7409/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015552377 CMS
PFIZER INC. $9.2109/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049837589 CMS
Pharmacyclics LLC, An AbbVie Company $21.8509/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026998287359 CMS
MorphoSys, US Inc. $131.3709/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261060325171 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $25,472.79 202
PY2020 $17,756.11 165
PY2021 $15,190.80 174
PY2022 $13,931.99 204
PY2023 $37,505.72 196
PY2024 $27,554.14 184
PY2025 $34,641.19 133

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
MAEN HUSSEIN, NPI 1356332506. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1356332506.
APA 7
IndustryPayments. (2026). MAEN HUSSEIN, NPI 1356332506 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1356332506
Bluebook
MAEN HUSSEIN, NPI 1356332506, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1356332506.

Source: Centers for Medicare & Medicaid Services, Open Payments.